ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0284

Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-induced Lupus Model

Gantsetseg Tumurkhuu1, Shuang Chen2, Erica Montano1, Malcolm Lane2, Michifumi Yamashita2, Janet Markman2, Luz Blanco3, Mariana Kaplan4, Kenichi Shimada2, Timothy Crother2, Mariko Ishimori2, Daniel J Wallace1, Caroline Jefferies5 and Moshe Arditi2, 1Cedars-Sinai Medical Center, Los Angeles, 2Cedars-Sinai Medical Center, Los Angeles, CA, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, Centreville, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, 5Cedars-Sinai Medical Center, West Hollywood, CA

Meeting: ACR Convergence 2020

Keywords: interferon, Mouse Models, Lupus, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic inflammatory autoimmune disease in which type I interferons (IFN) play a key role. The IFN response can be triggered when oxidized DNA engages the cytosolic DNA sensing platform cGAS-STING, but the repair mechanisms that modulate this process and govern disease progression are unclear. To gain insight into this biology, we interrogated the role of oxyguanine glycosylase 1 (OGG1), which repairs oxidized guanine 8-Oxo-2′-deoxyguanosine(8-OH-dG), in the pristane-induced mouse model of SLE.

Methods: C57/Bl6 (WT) and Ogg1 KO mice were injected i.p. with 0.5ml of pristane or PBS as control (WT-PBS). In order to observe the effects of Ogg1 deficiency in fully developed SLE, we analyzed the mice 10 months after induction. Histological features of skin and kidney were quantified by an image analysis system. Serum total IgG, IgG subtypes (IgG1 and IgG2a), and autoantibodies ( anti-dsDNA and anti-RNP) were measured by ELISA. Gene expression analysis for IFN and ISG genes was performed by RT-PCR using SYBR green.
Immune cell types were analyzed separately for each mouse by standard FACS procedures. Peripheral blood mononuclear cells (PBMCs) were separated from whole blood by density-gradient centrifugation with Ficoll-Paque Plus (GE Healthcare). CD14+ monocytes were purified from fresh PBMCs by positive selection using magnetic CD14+ beads (Miltenyi Biotec) according to the manufacturer’s protocol

Results: Ogg1-/- mice developed an exacerbated disease profile, characterized by aggravated skin pathology, increased auto-antibodies, higher total IgG, and higher splenic cell number. Neutrophils from pristane-treated Ogg1-/- mice exhibited earlier NETosis compared to WT. BMDMs from Ogg1-/- mice produced increased basal and cGAMP-driven IFN-β expression, which was diminished by treatment with the STING inhibitor H151, and skin lesions from pristine-treated Ogg1-/- mice had significantly higher expression of type I IFN genes than lesions in WT mice. Finally, expression of OGG1 was significantly lower in lesioned skin compared with non-lesioned skin in Discoid Lupus patients.

Conclusion: In conclusion, our study clearly supports a crucial role for OGG1 in protecting against IFN production and SLE skin disease.


Disclosure: G. Tumurkhuu, None; S. Chen, None; E. Montano, None; M. Lane, None; M. Yamashita, None; J. Markman, None; L. Blanco, None; M. Kaplan, None; K. Shimada, None; T. Crother, None; M. Ishimori, None; D. Wallace, None; C. Jefferies, None; M. Arditi, None.

To cite this abstract in AMA style:

Tumurkhuu G, Chen S, Montano E, Lane M, Yamashita M, Markman J, Blanco L, Kaplan M, Shimada K, Crother T, Ishimori M, Wallace D, Jefferies C, Arditi M. Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-induced Lupus Model [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/oxidative-dna-damage-accelerates-skin-inflammation-in-pristane-induced-lupus-model/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/oxidative-dna-damage-accelerates-skin-inflammation-in-pristane-induced-lupus-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology